Evidence map›Paper›PMID 36770987›Full record

ArticleMolecules (Basel, Switzerland)2023

Neuroprotection by Skimmianine in Lipopolysaccharide-Activated BV-2 Microglia.

Folashade A Ogunrinade, Victoria U Iwuanyanwu, Satyajit D Sarker, Olumayokun A Olajide

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Folashade A OgunrinadeDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.
Victoria U IwuanyanwuDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.ORCID 0000-0002-2071-2035
Satyajit D SarkerCentre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, Byrom Street, Liverpool L3 3AF, UK.ORCID 0000-0003-4038-0514
Olumayokun A OlajideDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.ORCID 0000-0002-9254-8334
University of Huddersfield · GBLiverpool John Moores University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skimmianine is a furoquinoline alkaloid which is found in the

Indexed as

NeuroprotectionQuinolinesAnimalsCell LineCulture Media, ConditionedCyclooxygenase 2Interleukin-6LipopolysaccharidesMiceMicrogliaNF-kappa BNF-KappaB Inhibitor alphaTumor Necrosis Factor-alphaCulture Media, ConditionedCyclooxygenase 2Interleukin-6LipopolysaccharidesNF-kappa BNF-KappaB Inhibitor alphaQuinolinesskimmianineTumor Necrosis Factor-alphamicroglianatural productsneuroinflammationneuronsneuroprotectionskimmianine

Identifiers

PMID36770987
PMCPMC9920223
OpenAlexW4318478740

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.